Introduction: Who Should Seek Diagnostics and When

If you experience new pain and stiffness that lasts more than a week, especially if it affects both sides of your body around the shoulders, neck, or hips, it is advisable to see a healthcare professional. This is particularly important if you are over 50 years of age, as polymyalgia rheumatica rarely affects younger people.^[1] The condition can develop very quickly, sometimes appearing to come on overnight, which is why prompt medical attention matters.^[2]

You should seek diagnostic testing if your morning stiffness lasts longer than 45 minutes and makes it difficult to perform everyday tasks such as getting dressed, brushing your hair, or getting out of bed.^[3] These symptoms can be so severe that they prevent you from sleeping well or carrying out normal daily activities.^[1] The pain is typically worse in the morning or after periods of rest, and it may improve somewhat with movement throughout the day.^[2]

People who notice additional symptoms alongside muscle pain should also seek medical evaluation. These include extreme tiredness, loss of appetite, unintentional weight loss, mild fever, or a general feeling of being unwell.^[3] Women and individuals of Northern European or Caucasian ancestry are at higher risk and should be especially attentive to these symptoms.^[2]

Because polymyalgia rheumatica symptoms are similar to those of many other conditions, including rheumatoid arthritis and fibromyalgia, diagnostic testing becomes essential to distinguish between these different diseases.^[3] Without proper diagnosis, the condition can interfere significantly with mobility, making it hard to bathe, dress, or perform other routine activities.^[2]

Diagnostic Methods for Identifying Polymyalgia Rheumatica

Diagnosing polymyalgia rheumatica can be challenging because there is no single specific test for the condition. Instead, doctors use a combination of approaches to confirm the diagnosis and rule out other diseases with similar symptoms.^[8] The diagnostic process typically begins with a thorough physical examination and continues with laboratory tests and sometimes imaging studies.

Physical Examination and Medical History

The physical exam is the first step in diagnosis. Your healthcare professional will check your joints and perform a neurological exam, which means testing how well your nervous system is working. During this examination, the doctor will gently move your head and limbs to assess your range of motion and identify areas of pain and stiffness.^[8] They will ask about when your symptoms started, how quickly they developed, and which parts of your body are affected.

The doctor will want to know whether the pain and stiffness occur on both sides of your body, whether symptoms are worse in the morning, and how long morning stiffness lasts. They will also ask about other symptoms such as fever, weight loss, fatigue, or problems with daily activities.^[2] This detailed history helps distinguish polymyalgia rheumatica from other conditions.

Blood Tests for Inflammation

Blood tests are a crucial part of diagnosing polymyalgia rheumatica. The main tests look for signs of inflammation, which means swelling and irritation inside the body. The two most important blood tests are the erythrocyte sedimentation rate, also called sed rate or ESR, and C-reactive protein, known as CRP.^[8]

These tests measure certain proteins in the blood that increase when inflammation is present. In polymyalgia rheumatica, these inflammation markers are typically elevated, meaning they show higher-than-normal levels. However, it is important to know that not everyone with polymyalgia rheumatica has high levels of these proteins in their blood, though most people do.^[8] This is why doctors do not rely on blood tests alone to make a diagnosis.

Your healthcare provider will also check your complete blood counts as part of the evaluation.^[8] These tests look at different components of your blood and can help identify other potential causes of your symptoms or detect related complications.

Imaging Tests

Imaging tests use technology to create pictures of the inside of your body. For polymyalgia rheumatica, these tests help doctors see inflammation in the joints and soft tissues, and they can also help rule out other causes of joint pain.^[8]

Ultrasound is commonly used and can show whether there is inflammation in the joints and soft tissues around the shoulders and hips. This test uses sound waves to create images and does not involve radiation. Some research suggests that the pain in polymyalgia rheumatica may be related to inflamed bursae, which are fluid-filled sacs that cushion the joints, particularly in the shoulders and hips.^[6]

Some people may have an MRI scan or a PET scan to look for other causes of joint pain and to examine tissues more closely.^[8] These advanced imaging techniques can provide detailed pictures that help doctors distinguish polymyalgia rheumatica from other conditions.

Response to Treatment as a Diagnostic Tool

Because there is no single definitive test for polymyalgia rheumatica, doctors sometimes use a trial of low-dose corticosteroid treatment as part of the diagnostic process. Corticosteroids are medications that reduce inflammation. If polymyalgia rheumatica is strongly suspected, a doctor may prescribe a low dose of a steroid called prednisone, usually 10 to 15 milligrams per day.^[6][13]

If polymyalgia rheumatica is present, the response to this medication can be dramatic. Many patients notice significant improvement in pain and stiffness within the first one to three days of taking the steroid. Sometimes improvement occurs after just one dose, though the response can be slower in some cases.^[13] If symptoms have not improved after two to three weeks of treatment, the diagnosis of polymyalgia rheumatica must be questioned, and doctors will consider other possible conditions.^[13]

Monitoring for Giant Cell Arteritis

Because polymyalgia rheumatica can occur alongside giant cell arteritis, your healthcare professional will carefully watch for symptoms that might indicate this more serious condition. Doctors look for warning signs such as new or persistent headaches, jaw pain or tenderness, blurred or double vision, vision loss, or a tender scalp.^[8]

To confirm a diagnosis of giant cell arteritis, you may need an ultrasound of the arteries or a biopsy of an artery in one of your temples. A biopsy involves removing a small sample of the artery to examine it under a microscope. This procedure is done with numbing medicine in the area where the tissue is removed.^[8]

Ruling Out Other Conditions

An important part of diagnosing polymyalgia rheumatica is making sure the symptoms are not caused by another disease. The symptoms can be similar to those of rheumatoid arthritis, fibromyalgia, and other inflammatory conditions.^[3] This is why blood tests, imaging studies, and careful physical examination are all necessary.

It is also worth noting that sometimes a diagnosis might change during treatment. Some people who are initially diagnosed with polymyalgia rheumatica are later found to have rheumatoid arthritis or giant cell arteritis instead.^[8] This is why ongoing monitoring and follow-up appointments are important.

Diagnostics for Clinical Trial Qualification

When patients with polymyalgia rheumatica are being considered for participation in clinical trials, they typically undergo a standardized set of diagnostic tests to confirm their eligibility. These tests ensure that participants truly have the condition and meet specific criteria required by the research study.

The standard diagnostic criteria for enrolling patients in clinical trials usually include blood tests measuring inflammation markers. The erythrocyte sedimentation rate and C-reactive protein tests are commonly used as baseline measures to document the presence and severity of inflammation at the start of a trial.^[4] Elevated levels of these markers are typical findings in polymyalgia rheumatica and help researchers confirm that participants have active disease.

Clinical trials may also require imaging studies such as ultrasound to document inflammation in specific joints and soft tissues before treatment begins. This provides objective evidence of the disease and allows researchers to track changes over time as different treatments are tested.^[8]

Additional eligibility criteria often include age requirements, since polymyalgia rheumatica almost exclusively affects people over 50 years of age. Researchers may also screen for the presence or absence of giant cell arteritis, as some trials focus specifically on polymyalgia rheumatica without arteritis, while others may include both conditions.^[2]

Participants in clinical trials typically undergo more frequent blood tests and imaging studies than they would in routine clinical care. This allows researchers to carefully monitor how well treatments are working, track inflammation levels, and watch for side effects. Follow-up appointments may occur every few weeks during the trial to collect this data and ensure patient safety.^[11]

Some clinical trials also test newer diagnostic approaches or biomarkers that might help identify polymyalgia rheumatica more quickly or accurately. These research studies contribute to improving diagnostic methods for future patients, even though the approaches being tested are not yet part of standard medical practice.